A single dose of typhoid conjugate vaccine (TCV) offers safe, effective protection against typhoid two years after vaccination in all children, and sustained protection for older children at three to ...

A single dose of the typhoid conjugate vaccine, Typbar TCV, provides lasting efficacy in preventing typhoid fever in children ages nine months to 12 years old, according to a new study conducted by ...

For one terrible night in March 2010, in a field clinic outside Port-au-Prince, Haiti, I watched a child die of typhoid fever. She had arrived earlier in the day from a tent city, one of many wretched ...

Randomized controlled trials among children in Asia and Africa have revealed a high short-term efficacy of typhoid conjugate vaccines; however, few studies have analyzed the persistence of protection ...

The use of combination or combined vaccines is an effective strategy to improve compliance and coverage in immunization schedules. However, it is reliant on the demonstration that coadministration of ...

November 9, 2023, SEOUL, Republic of Korea and BANDUNG, Indonesia — The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, ...

A novel vaccine designed to combat both typhoid fever and invasive non-typhoidal Salmonella (iNTS) infections has shown promising results in an initial human trial, raising hopes for better protection ...

A single dose of the typhoid conjugate vaccine, Typbar TCV, provides lasting efficacy in preventing typhoid fever in children ages 9 months to 12 years old, according to a new study. A single dose of ...

A single dose of the typhoid conjugate vaccine, Typbar TCV®, provides lasting efficacy in preventing typhoid fever in children ages 9 months to 12 years old, according to a new study conducted by ...